elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26746194-190E560E-FA4F-435D-842F-483F5E2531E7
Q26746194-190E560E-FA4F-435D-842F-483F5E2531E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26746194-190E560E-FA4F-435D-842F-483F5E2531E7
Anti-nerve growth factor in pain management: current evidence
P2860
Q26746194-190E560E-FA4F-435D-842F-483F5E2531E7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26746194-190E560E-FA4F-435D-842F-483F5E2531E7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3aebdbfb1081bef94ebb46823a06cbef2f566395
P2860
Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance.